The decision to add B12 is made by individual prescribers working with compounding pharmacies, which is why B12 only appears in compounded formulations
Different pathways addressing the same problem create more comprehensive inflammation control without the tissue-weakening effects of pharmaceutical anti-inflammatories
compounding pharmacies that follow FDA and state pharmacy board guidelines
Templates available at stopthebop.com
1419, PL-10, PLD-116, PL 14736), in trials for inflammatory bowel disease (LD1 not achieved), wound and fistulas treatment (1-7, 27, 29, 33-37) (i.e., stimulation of expression of the early growth response 1 (egr-1) gene (38), and other molecular pathways (38-42), effective alone without carrier (1-7) it has a particular effect on endothelium protection along with prominent angiogenesis (1, 43-47) and an effect on NO-system (1-7)